跳至主要内容
临床试验/NCT07449962
NCT07449962尚未招募不适用

Effect of Lifestyle Medicine Assessment Tool-Guided Counselling Compared to Usual Care Counselling in Adult Patients With Hypertension. A Randomized Control Trial.

Indus Hospital and Health Network1 个研究点 分布在 1 个国家目标入组 126 人开始时间: 2027年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
126
试验地点
1
主要终点
Change in systolic blood pressure

研究概览

简要总结

The goal of this clinical trial is to learn if knowing and understanding a patient's daily habits and then giving clear advice on what changes to make can help control blood pressure better than the routine way of advising people with high blood pressure. The main questions it aims to answer are:

  • To learn if using the Lifestyle Medicine Assessment tool (A 21-item questionnaire) to understand the current lifestyle of people with hypertension and guide them accordingly, helps in lowering blood pressure more, as compared to routine advice?
  • To see if this way of guiding patients results in more positive lifestyle changes than routine advice? Researchers will compare two groups of people with hypertension. One will be guided after assessing their current lifestyle with the Lifestyle Medicine Assessment Tool and one will be given routine guidance. The researchers will then see which group had better blood pressure control.

Participants will be:

• Asked a few questions about their lifestyle and then they will be advised accordingly on ways to make it better.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients aged 18-65 yrs with diagnosed primary/essential hypertension, defined as two or more clinic BP readings of ≥130/80 (ACC/AHA Guidelines).
  • If taking anti hypertensives, then on a stable regime i.e. no recent medication change for at least ≥4 weeks.
  • Willing and able to participate in the study.

排除标准

  • Diagnosed secondary hypertension.
  • Moderate to severe CKD (eGFR <60 ml/min/1.73m2).
  • Moderate to severe ischemic heart disease.
  • Diabetes Mellitus requiring insulin.
  • Major psychiatric disorder such as dementia or schizophrenia.
  • Pregnancy or Lactating mother.
  • Unable to participate in study/ Severe mobility limitation.

研究组 & 干预措施

Control Group

No Intervention

The patients in the control group will complete the LMA questionnaire and their scores will be noted without revealing them to the participants. They will receive the usual routine counselling comprised of advice to reduce salt intake and increase daily physical activity.

Intervention Group

Experimental

Patients in the intervention group will complete the Lifestyle Medicine Assessment (LMA) questionnaire, and structured counselling will be delivered according to their scores in each domain. To keep the counselling consistent and standardized throughout the study a checklist will be formulated according to the current guidelines on lifestyle modification for hypertensive patients, consisting of counselling items pertaining to each domain, and it will be followed for all patients in the intervention group.

干预措施: Lifestyle Intervention (Behavioral)

结局指标

主要结局

Change in systolic blood pressure

时间窗: From enrolment to the end of follow-up at three months

Change in systolic blood pressure from baseline to the third month, measured at monthly intervals. The effect of the intervention will be evaluated as the difference in mean change between the intervention and control groups over time.

次要结局

  • Change in lifestyle factors(From baseline to the three-month follow-up.)
  • Patient satisfaction(At the end of three-month follow-up)

研究者

发起方
Indus Hospital and Health Network
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Hafiz Muhammad Abu Baker Mahmood

Principal Investigator

Indus Hospital and Health Network

研究点 (1)

Loading locations...

相似试验